Trump Signs Order to Reduce Regulatory Barriers to Domestic Pharmaceutical Manufacturing

White House: Trump Signs Order to Reduce Regulatory Barriers to Domestic Pharmaceutical Manufacturing

• Trump order directs the FDA to reduce the amount of time it takes to approve domestic pharmaceutical manufacturing plants.
• Trump order directs the FDA to increase fees for and inspections of foreign manufacturing plants.
  
• Trump order directs FDA to improve enforcement of active pharmaceutical ingredient source reporting by foreign drug producers and consider publicly displaying a list of facilities that do not comply.
• Trump order directs EPA to accelerate construction of facilities designed to manufacture prescription drugs, active pharmaceutical ingredients, and other necessary raw materials
  

You May Also Be Interested In

• Apple (AAPL) spreader of 5K contracts of September 17 weekly 350 and September 300 calls into hosting a special event
• BofA Securities Downgrades Amrize Ltd (AMRZ) to Underperform
• Amazon (AMZN) call put ratio 1.6 calls 1 put with a focus on September 2 weekly 257.50 calls